This is a preprint.
A multilayered post-GWAS analysis pipeline defines functional variants and target genes for systemic lupus erythematosus (SLE)
- PMID: 37066327
- PMCID: PMC10104240
- DOI: 10.1101/2023.04.07.23288295
A multilayered post-GWAS analysis pipeline defines functional variants and target genes for systemic lupus erythematosus (SLE)
Update in
-
A Multilayered Post-Genome-Wide Association Study Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus.Arthritis Rheumatol. 2024 Jul;76(7):1071-1084. doi: 10.1002/art.42829. Epub 2024 Mar 26. Arthritis Rheumatol. 2024. PMID: 38369936 Free PMC article.
Abstract
Objectives: Systemic lupus erythematosus (SLE), an autoimmune disease with incompletely understood etiology, has a strong genetic component. Although genome-wide association studies (GWAS) have revealed multiple SLE susceptibility loci and associated single nucleotide polymorphisms (SNPs), the precise causal variants, target genes, cell types, tissues, and mechanisms of action remain largely unknown.
Methods: Here, we report a comprehensive post-GWAS analysis using extensive bioinformatics, molecular modeling, and integrative functional genomic and epigenomic analyses to optimize fine-mapping. We compile and cross-reference immune cell-specific expression quantitative trait loci ( cis - and trans -eQTLs) with promoter-capture Hi-C, allele-specific chromatin accessibility, and massively parallel reporter assay data to define predisposing variants and target genes. We experimentally validate a predicted locus using CRISPR/Cas9 genome editing, qPCR, and Western blot.
Results: Anchoring on 452 index SNPs, we selected 9,931 high-linkage disequilibrium (r 2 >0.8) SNPs and defined 182 independent non-HLA SLE loci. 3,746 SNPs from 143 loci were identified as regulating 564 unique genes. Target genes are enriched in lupus-related tissues and associated with other autoimmune diseases. Of these, 329 SNPs (106 loci) showed significant allele-specific chromatin accessibility and/or enhancer activity, indicating regulatory potential. Using CRISPR/Cas9, we validated rs57668933 as a functional variant regulating multiple targets, including SLE risk gene ELF1 , in B-cells.
Conclusion: We demonstrate and validate post-GWAS strategies for utilizing multi-dimensional data to prioritize likely causal variants with cognate gene targets underlying SLE pathogenesis. Our results provide a catalog of significantly SLE-associated SNPs and loci, target genes, and likely biochemical mechanisms, to guide experimental characterization.
Similar articles
-
A Multilayered Post-Genome-Wide Association Study Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus.Arthritis Rheumatol. 2024 Jul;76(7):1071-1084. doi: 10.1002/art.42829. Epub 2024 Mar 26. Arthritis Rheumatol. 2024. PMID: 38369936 Free PMC article.
-
Mechanistic Characterization of RASGRP1 Variants Identifies an hnRNP-K-Regulated Transcriptional Enhancer Contributing to SLE Susceptibility.Front Immunol. 2019 May 20;10:1066. doi: 10.3389/fimmu.2019.01066. eCollection 2019. Front Immunol. 2019. PMID: 31164884 Free PMC article.
-
Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus.Arthritis Rheumatol. 2023 Apr;75(4):574-585. doi: 10.1002/art.42390. Epub 2023 Feb 8. Arthritis Rheumatol. 2023. PMID: 36245280
-
A review of genetic risk in systemic lupus erythematosus.Expert Rev Clin Immunol. 2023 Jul-Dec;19(10):1247-1258. doi: 10.1080/1744666X.2023.2240959. Epub 2023 Jul 26. Expert Rev Clin Immunol. 2023. PMID: 37496418 Review.
-
The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned.J Autoimmun. 2016 Nov;74:161-175. doi: 10.1016/j.jaut.2016.08.001. Epub 2016 Aug 10. J Autoimmun. 2016. PMID: 27522116 Review.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials